Minimizing interfacial liquid–solid contact is central to self-cleaning and protective fabrics, yet passive microtextures generally permit transient contact during impact. Here, we demonstrate a bio-inspired airflow-mediated strategy that converts superhydrophobic fabrics from passive low-adhesion surfaces into pressure-programmable active repellent interfaces. This strategy is implemented by covalently anchoring continuous nanoscale superhydrophobic shells onto the microscale fibers, which maintains a low-adhesion interfacial Cassie-type wetting state at the nanoscale even after 20,000 abrasion cycles, 15,300 scrub resistance cycles, and 3000 bending cycles, and delivering airflow through interconnected fabric pores to supply a replenishable interfacial counter-pressure required for levitating and redirecting impacting droplets of 2–20 μL (equivalent spherical diameters ≈ 1.6–3.4 mm). A pressure-controlled sequence is resolved from contact rebound to suspended rebound and finally to an operational zero-contact rebound, defined as no liquid–solid contact. Compared with conventional optical imaging, synchrotron X-ray imaging at 10,000 frames s–1 with 2 μm spatial resolution enhanced the detection resolution. Nanostructure-reinforced surface superhydrophobicity reduces interfacial adhesion and pore-invasion risks and provides fail-safe repellency below the zero-contact airflow threshold. The threshold pressure for zero-contact rebound is found as a scaling correlation in terms of droplet impact velocity and fabric pore size. The coupled droplet–gas-film–fabric model separates liquid inertial–deformation demand from gas-flow loss in the fabric, with a globally calibrated two-coefficient linear–quadratic relation describing the measured velocity–pressure pairs. The proof-of-concept demonstrations on breathable masks, tents, and garments illustrate how these nanostructure-enhanced superhydrophobic fabrics can assist in spray and fog protection and modulate surface temperature and local infrared temperature contrast.
No takes yet. Share an insight, caveat, or question.
Peng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: